Saint Julien-en Genevois, France

Patrick Naxos Page

USPTO Granted Patents = 26 


 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 147(Granted Patents)


Location History:

  • Savonni, FR (2012 - 2013)
  • Saint-Julie-en-Genevois, FR (2013)
  • Saint-Julien-en-Genevois, FR (2006 - 2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: Innovations by Patrick Naxos Page: A Pioneer in Pharmaceutical Patents

Introduction: Patrick Naxos Page, a distinguished inventor based in Saint Julien-en Genevois, France, has made significant contributions to the pharmaceutical field with a remarkable portfolio of 26 patents. His innovative work focuses on developing new therapeutics that target critical health issues, particularly in the realm of pregnancy and oxidative stress conditions.

Latest Patents: Among Patrick's latest inventions are two noteworthy patents. The first patent, titled "Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof," details compounds that can inhibit prostaglandin F receptor, with potential applications in treating disorders like preterm labor at early gestational stages. The second patent, related to "Pyrazolo pyridine derivatives as NADPH oxidase inhibitors," introduces derivatives that could be pivotal in treating disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

Career Highlights: Throughout his career, Patrick has worked with prominent organizations that underscore his expertise and commitment to innovation. Notably, he has held positions at Genkyotex and Merck Serono, S.A., both of which are esteemed companies in the pharmaceutical industry. His tenure in these organizations has allowed him to push the boundaries of medical science through steadfast research and development.

Collaborations: Collaboration has been at the heart of Patrick's innovative journey. He has worked closely with colleagues like Mike Orchard and Francesca Gaggini, contributing to a dynamic environment that fosters creative solutions and leads to groundbreaking inventions. These partnerships have significantly enriched his research and broadened the impact of his work.

Conclusion: Patrick Naxos Page exemplifies the spirit of innovation in the pharmaceutical sector through his extensive patent portfolio and collaborative efforts. His latest inventions hold promise for treating critical health conditions, showcasing how dedicated inventors like him continue to shape the future of medicine through their groundbreaking contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…